- Investing Ideas
- Canadian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Canadian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
4
0 new
Mid-Large Cap Stocks
4 companies
Curaleaf Holdings
Market Cap: CA$4.0b
Engages in the retail and wholesale of cannabis products in the United States and internationally.
CURA
CA$14.50
7D
2.2%
1Y
324.0%
Cronos Group
Market Cap: CA$1.5b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$3.84
7D
2.1%
1Y
42.2%
Green Thumb Industries
Market Cap: CA$2.6b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$11.80
7D
11.8%
1Y
69.8%
Trulieve Cannabis
Market Cap: CA$3.1b
Operates as a cannabis retailer in the United States.
TRUL
CA$16.14
7D
16.9%
1Y
215.9%